Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ORASURE TECHNOLOGIES INCOSUR · Entity 6152 | President of Diagnostics | May 11, 2022 | May 12, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ORASURE TECHNOLOGIES INC
Report date May 11, 2022 · Filed May 12, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 123,479 |
Reported balance
After 2022-05-11 transaction · row 1
1 source rowRow 1 · 2022-05-11 · Tax withholding · Disposed 1,606 · Balance 123,479 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 11, 2022 Filed May 12, 2022 20:05 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 1,606 | $5.06 | $8,118.33 |
DisclosureSEC source: 0001062993-22-012238 · form4.xml · nonDerivative · entry 1 Nibauer Lisa · CIK 0001811937 · President of Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,479 Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:51 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 34,556 | $8.86 | $306,166.16 |
DisclosureSEC source: 0001593968-22-000404 · primary_01.xml · nonDerivative · entry 2 Nibauer Lisa · CIK 0001811937 · President-Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,085 F2 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 21:51 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 2,606 | $8.86 | $23,089.16 |
DisclosureSEC source: 0001593968-22-000404 · primary_01.xml · nonDerivative · entry 1 Nibauer Lisa · CIK 0001811937 · President-Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,529 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| January 05, 2022 Filed Jan 7, 2022 21:49 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 60,901 | $8.21 | $499,997.21 |
DisclosureSEC source: 0001593968-22-000179 · primary_01.xml · nonDerivative · entry 1 Nibauer Lisa · CIK 0001811937 · President-Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,135 F1 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:15 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | Tax withholdingCommon Stock | 1,606 | $9.55 | $15,337.30 |
DisclosureSEC source: 0001593968-21-001313 · primary_01.xml · nonDerivative · entry 1 Nibauer Lisa · CIK 0001811937 · EVP & BU Lead-Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,234 F1 · kind: Withholding of shares to pay the tax liability associated with vesting of restricted shares Read SEC document |
| February 01, 2021 Filed Feb 2, 2021 22:11 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 19,769 | $15.55 | $307,504.82 |
DisclosureSEC source: 0001593968-21-000330 · primary_01.xml · nonDerivative · entry 1 Nibauer Lisa · CIK 0001811937 · EVP & BU Lead-Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,840 F1 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:16 UTC | ORASURE TECHNOLOGIES INC OSUR · Entity 6152 | GrantCommon Stock | 14,071 | $17.77 | $250,006.49 |
DisclosureSEC source: 0001593968-20-001156 · primary_01.xml · nonDerivative · entry 1 Nibauer Lisa · CIK 0001811937 · EVP & BU Lead - Infectious 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,071 F1 · kind: Restricted stock award with 3 year vesting schedule Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.